BELGRADE, Mont. , April 28, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary allograft, today announced that its Acellular Dermal Matrix allograft (ADM), hMatrix®, has received coverage from Novitas Solutions, Inc.

BELGRADE, Mont. , April 23, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary bone graft material, today announced that it will release its financial results for the period ended March 31, 2015 , on May 5, 2015 at the close of

First Quarter Total Revenue Expected to be in the Range of $9.4 Million to $9.5 Million, an Increase of Approximately 5-7% Over the Same Period Last Year BELGRADE, Mont. , April 9, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of

BELGRADE, Mont. , April 8, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material, today announced that it received written notice from the staff at NYSE Regulation, Inc.

BELGRADE, Mont. , April 6, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts, is pleased to announce that the United States Patent and Trademark Office has issued US Patent No.

Fourth Quarter Highlights: Total revenue increased to $9.1 million from $8.3 million in Q4 2013, an increase of 10.0% over the prior year Gross profit increased to $5.8 million compared to $4.1 million in Q4 2013, an increase of 41.2% over the prior year Gross margins improved to 63.5%, an increase

BELGRADE, Mont. , March 16, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material, today announced that it has extended its contract with Novation for an additional year. The extension will allow Bacterin to continue to

BELGRADE, Mont. , March 11, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts, today announced that its CEO, Dan Goldberger , will present at the Canaccord Genuity Musculoskeletal Conference , to be held March

BELGRADE, Mont. , March 10, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material, today announced it has signed a national distribution agreement with Spartan Medical, Inc. , a service-disabled, veteran-owned, small

BELGRADE, Mont. , March 2, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material, today announced that it will release its financial results for the period and full year ended December 31, 2014 , on March 17,